HUG at a glance
The HUG: cutting-edge treatment, teaching and research
Geneva University Hospitals (HUG), a leading national and international academic institution, brings together eight public hospitals and two clinics.
Geneva University Hospitals (HUG), a leading national and international academic institution, brings together eight public hospitals and two clinics.
Les Hôpitaux universitaires de Genève (HUG), établissement universitaire de référence au niveau national et international, rassemblent huit hôpitaux publics et deux cliniques.
All healthcare areas and patients included, a day in hospital costs an average of 1,360 Swiss francs. From 800 Swiss francs in rehabilitation to 7,000 Swiss francs in intensive care, the cost (*) per patient varies depending on the use of the technical facilities and the type of care.
Toutes zones de soins et patients confondus, une journée à l’hôpital coûte en moyenne 1’360 francs. De 800 francs en réadaptation à 7’000 francs aux soins intensifs, le coût* par patient varie en fonction de l’utilisation du plateau technique et du type de soins.
The HUG Private Foundation is the foundation of the Geneva University Hospitals and the University of Geneva’s Faculty of Medicine. It devotes – with complete transparency and rigour – all of the donations made by individuals and groups to funding essential projects to promote medical knowledge and quality healthcare for the good of all patients, whatever their disease.
To diagnose Alzheimer’s disease, neuroimaging techniques (MRI, PET) may be used to determine certain biomarkers. However, this data remains incomplete.
This has prompted an international team, steered by Professor Giovanni Frisoni, director of HUG’s memory centre (FR), to adapt the approach used for cancer to Alzheimer’s disease.
Pour diagnostiquer la maladie d’Alzheimer, les techniques de neuroimagerie (IRM, PET) peuvent être utilisées pour déterminer certains biomarqueurs. Mais ces données restent incomplètes.
A study conducted by the palliative medicine service aims to assess the interest of using dexmedetomidine (Dex) during painful nursing care.
Menée par le service de médecine palliative, une étude a pour but d’évaluer l’intérêt d’utiliser la dexmedetomidine (Dex) lors de soins infirmiers douloureux.